Letter: Monoamine oxidase and migraine

Migraine: the platelet hypothesis after 10 years.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·1989

Migraine: a platelet disorder.

Lancet (London, England)·1981

Migraine. A platelet hypothesis.

Biomedicine / [publiee pour l'A.A.I.C.I.G.]·1979

Migraine: A blood disorder?

Lancet (London, England)·1978

Efficacy and safety of upadacitinib in adults and adolescents for treatment of non-segmental vitiligo (Viti-Up): results of two phase 3 randomised controlled studies.

Lancet (London, England)·2026

Belzutifan plus lenvatinib versus cabozantinib in patients with previously treated advanced renal cell carcinoma (LITESPARK-011): an open-label, randomised, controlled, phase 3 trial.

Lancet (London, England)·2026

Switch to once-weekly, single-tablet islatravir-lenacapavir from daily standard of care for HIV-1 (ISLEND-2): a multicentre, randomised, open-label, active-controlled, phase 3 non-inferiority trial.

Lancet (London, England)·2026

[177Lu]Lu-PSMA-617 in patients with PSMA-positive metastatic androgen pathway modulator-naive/sensitive prostate cancer (PSMAddition): a phase 3 randomised, controlled trial.

Lancet (London, England)·2026

Oxygen Vacancy and Alkali Ion-Assisted Nitrogen Fixation with Efficient Solar Ammonia Production over NiTiO3 Based Photocatalysts.

ACS applied materials & interfaces·2026

Electrochemically Driven Regioselective Radical Functionalization of Allenes: Scope and Mechanistic Insights.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026

Asymmetric Kinetic Resolution of 2-Aryl Oxetanes by Dinuclear Titanium Radical Catalysis.

Angewandte Chemie (International ed. in English)·2026

Exogenous kinetin mitigates arsenic-induced oxidative stress by regulating ROS homeostasis and antioxidant defense in Ocimum basilicum L.

Plant cell reports·2026

ROS-responsive carrier-free nanodrugs for three-pronged acute ischemic stroke therapy.

Materials today. Bio·2026

Investigation of the Nrf2-Keap1 signaling pathway's response to oxidative stress in Meretrix meretrix.

Ecotoxicology and environmental safety·2026

Related Experiment Videos

Letter: Monoamine oxidase and migraine

Related Concept Videos

Migraine: the platelet hypothesis after 10 years.

Migraine: a platelet disorder.

Migraine. A platelet hypothesis.

Migraine: A blood disorder?

Efficacy and safety of upadacitinib in adults and adolescents for treatment of non-segmental vitiligo (Viti-Up): results of two phase 3 randomised controlled studies.

Belzutifan plus lenvatinib versus cabozantinib in patients with previously treated advanced renal cell carcinoma (LITESPARK-011): an open-label, randomised, controlled, phase 3 trial.

Switch to once-weekly, single-tablet islatravir-lenacapavir from daily standard of care for HIV-1 (ISLEND-2): a multicentre, randomised, open-label, active-controlled, phase 3 non-inferiority trial.

[177Lu]Lu-PSMA-617 in patients with PSMA-positive metastatic androgen pathway modulator-naive/sensitive prostate cancer (PSMAddition): a phase 3 randomised, controlled trial.

Oxygen Vacancy and Alkali Ion-Assisted Nitrogen Fixation with Efficient Solar Ammonia Production over NiTiO3 Based Photocatalysts.

Electrochemically Driven Regioselective Radical Functionalization of Allenes: Scope and Mechanistic Insights.

Asymmetric Kinetic Resolution of 2-Aryl Oxetanes by Dinuclear Titanium Radical Catalysis.

Exogenous kinetin mitigates arsenic-induced oxidative stress by regulating ROS homeostasis and antioxidant defense in Ocimum basilicum L.

ROS-responsive carrier-free nanodrugs for three-pronged acute ischemic stroke therapy.

Investigation of the Nrf2-Keap1 signaling pathway's response to oxidative stress in Meretrix meretrix.

Related Experiment Videos

Letter: Monoamine oxidase and migraine

Related Concept Videos

Related Articles